Correlation Between Tonix Pharmaceuticals and Anixa Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tonix Pharmaceuticals and Anixa Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tonix Pharmaceuticals and Anixa Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tonix Pharmaceuticals Holding and Anixa Biosciences, you can compare the effects of market volatilities on Tonix Pharmaceuticals and Anixa Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tonix Pharmaceuticals with a short position of Anixa Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tonix Pharmaceuticals and Anixa Biosciences.

Diversification Opportunities for Tonix Pharmaceuticals and Anixa Biosciences

0.08
  Correlation Coefficient

Significant diversification

The 3 months correlation between Tonix and Anixa is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Tonix Pharmaceuticals Holding and Anixa Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anixa Biosciences and Tonix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tonix Pharmaceuticals Holding are associated (or correlated) with Anixa Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anixa Biosciences has no effect on the direction of Tonix Pharmaceuticals i.e., Tonix Pharmaceuticals and Anixa Biosciences go up and down completely randomly.

Pair Corralation between Tonix Pharmaceuticals and Anixa Biosciences

Given the investment horizon of 90 days Tonix Pharmaceuticals Holding is expected to under-perform the Anixa Biosciences. In addition to that, Tonix Pharmaceuticals is 2.27 times more volatile than Anixa Biosciences. It trades about -0.21 of its total potential returns per unit of risk. Anixa Biosciences is currently generating about 0.08 per unit of volatility. If you would invest  243.00  in Anixa Biosciences on August 29, 2024 and sell it today you would earn a total of  88.00  from holding Anixa Biosciences or generate 36.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Tonix Pharmaceuticals Holding  vs.  Anixa Biosciences

 Performance 
       Timeline  
Tonix Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tonix Pharmaceuticals Holding has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest unfluctuating performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.
Anixa Biosciences 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Anixa Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong forward indicators, Anixa Biosciences is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Tonix Pharmaceuticals and Anixa Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tonix Pharmaceuticals and Anixa Biosciences

The main advantage of trading using opposite Tonix Pharmaceuticals and Anixa Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tonix Pharmaceuticals position performs unexpectedly, Anixa Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anixa Biosciences will offset losses from the drop in Anixa Biosciences' long position.
The idea behind Tonix Pharmaceuticals Holding and Anixa Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance